FI940098A - Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä - Google Patents
Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä Download PDFInfo
- Publication number
- FI940098A FI940098A FI940098A FI940098A FI940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A
- Authority
- FI
- Finland
- Prior art keywords
- bdnf
- treatment
- molecules
- members
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Water Treatments (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Water Treatment By Sorption (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72770491A | 1991-07-10 | 1991-07-10 | |
| PCT/US1992/004228 WO1993001300A1 (en) | 1991-07-10 | 1992-05-19 | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI940098A0 FI940098A0 (fi) | 1994-01-10 |
| FI940098A true FI940098A (fi) | 1994-03-10 |
Family
ID=24923677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940098A FI940098A (fi) | 1991-07-10 | 1994-01-10 | Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP0593516B1 (pt) |
| JP (1) | JPH06509094A (pt) |
| CN (1) | CN1065768C (pt) |
| AT (1) | ATE202939T1 (pt) |
| AU (2) | AU675409B2 (pt) |
| CA (1) | CA2113083A1 (pt) |
| DE (1) | DE69231930T2 (pt) |
| DK (1) | DK0593516T3 (pt) |
| ES (1) | ES2157903T3 (pt) |
| FI (1) | FI940098A (pt) |
| GR (1) | GR3036776T3 (pt) |
| HU (1) | HUT70275A (pt) |
| IE (1) | IE921602A1 (pt) |
| IL (1) | IL101928A0 (pt) |
| NO (1) | NO940084L (pt) |
| PT (1) | PT100501A (pt) |
| RU (1) | RU94016525A (pt) |
| SK (1) | SK2694A3 (pt) |
| WO (1) | WO1993001300A1 (pt) |
| ZA (1) | ZA923639B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07509600A (ja) * | 1992-06-12 | 1995-10-26 | リジェネロン ファーマシューティカルズ，インコーポレーテッド | ニューロトロフィン−４発現に基づく治療および診断法 |
| FR2717496B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
| CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
| AU5945301A (en) | 2000-05-05 | 2001-11-20 | Res Foundation Of City Univers | Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| CN101084303A (zh) * | 2004-11-17 | 2007-12-05 | 神经干公司 | 用于治疗神经变性症状的人类神经细胞的移植 |
| WO2008156418A1 (en) * | 2007-06-19 | 2008-12-24 | Astrazeneca Ab | A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
| EP2572729A3 (en) * | 2007-08-10 | 2013-06-05 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human nerve growth factor |
| WO2014111525A2 (en) | 2013-01-18 | 2014-07-24 | Anaxomics Biotech, Sl | New combination therapies for treating nervous system diseases |
| US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
| WO2023164311A2 (en) * | 2022-02-28 | 2023-08-31 | Bioincept, Llc | Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923696A (en) * | 1987-05-04 | 1990-05-08 | Baylor College Of Medicine | Method to prepare a neurotrophic composition |
| GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
| US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
| IE903130A1 (en) * | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
-
1992
- 1992-05-19 AU AU20095/92A patent/AU675409B2/en not_active Ceased
- 1992-05-19 RU RU94016525/14A patent/RU94016525A/ru unknown
- 1992-05-19 CN CN92105070A patent/CN1065768C/zh not_active Expired - Fee Related
- 1992-05-19 EP EP92912453A patent/EP0593516B1/en not_active Expired - Lifetime
- 1992-05-19 AT AT92912453T patent/ATE202939T1/de not_active IP Right Cessation
- 1992-05-19 HU HU9400063A patent/HUT70275A/hu unknown
- 1992-05-19 SK SK26-94A patent/SK2694A3/sk unknown
- 1992-05-19 DK DK92912453T patent/DK0593516T3/da active
- 1992-05-19 IL IL101928A patent/IL101928A0/xx unknown
- 1992-05-19 ZA ZA923639A patent/ZA923639B/xx unknown
- 1992-05-19 CA CA2113083A patent/CA2113083A1/en not_active Abandoned
- 1992-05-19 EP EP96111711A patent/EP0755682A1/en not_active Withdrawn
- 1992-05-19 DE DE69231930T patent/DE69231930T2/de not_active Expired - Lifetime
- 1992-05-19 JP JP5502202A patent/JPH06509094A/ja active Pending
- 1992-05-19 PT PT100501A patent/PT100501A/pt not_active Application Discontinuation
- 1992-05-19 WO PCT/US1992/004228 patent/WO1993001300A1/en active IP Right Grant
- 1992-05-19 ES ES92912453T patent/ES2157903T3/es not_active Expired - Lifetime
- 1992-07-01 IE IE160292A patent/IE921602A1/en not_active Application Discontinuation
-
1994
- 1994-01-10 NO NO940084A patent/NO940084L/no unknown
- 1994-01-10 FI FI940098A patent/FI940098A/fi not_active Application Discontinuation
-
1996
- 1996-11-08 AU AU70676/96A patent/AU7067696A/en not_active Abandoned
-
2001
- 2001-10-03 GR GR20010401637T patent/GR3036776T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993001300A1 (en) | 1993-01-21 |
| JPH06509094A (ja) | 1994-10-13 |
| RU94016525A (ru) | 1996-06-10 |
| DE69231930D1 (de) | 2001-08-16 |
| AU2009592A (en) | 1993-02-11 |
| HUT70275A (en) | 1995-09-28 |
| AU7067696A (en) | 1997-01-16 |
| HU9400063D0 (en) | 1994-06-28 |
| EP0593516B1 (en) | 2001-07-11 |
| EP0755682A1 (en) | 1997-01-29 |
| CN1065768C (zh) | 2001-05-16 |
| DK0593516T3 (da) | 2001-09-17 |
| EP0593516A1 (en) | 1994-04-27 |
| DE69231930T2 (de) | 2002-04-11 |
| ZA923639B (en) | 1993-02-24 |
| FI940098A0 (fi) | 1994-01-10 |
| IE921602A1 (en) | 1993-01-13 |
| CA2113083A1 (en) | 1993-01-21 |
| IL101928A0 (en) | 1992-12-30 |
| ES2157903T3 (es) | 2001-09-01 |
| NO940084D0 (no) | 1994-01-10 |
| ATE202939T1 (de) | 2001-07-15 |
| PT100501A (pt) | 1993-09-30 |
| CN1071585A (zh) | 1993-05-05 |
| NO940084L (no) | 1994-03-08 |
| GR3036776T3 (en) | 2002-01-31 |
| EP0593516A4 (en) | 1995-01-18 |
| AU675409B2 (en) | 1997-02-06 |
| SK2694A3 (en) | 1995-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI940098A (fi) | Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä | |
| NO951592L (no) | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system | |
| FI108146B (fi) | Biologisesti aktiivisten, neurotrofisten NGF/BDNF-sarjan yhdistelmäproteiinien valmistus | |
| PT88385A (pt) | Process for preparing conjugates of citokines with immunoglobulins | |
| DE59108854D1 (de) | Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| ATE199167T1 (de) | Nichtglykosyliertes fgf-4 und dieses enthaltende präparate | |
| DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
| DE3887194D1 (de) | Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung. | |
| GR3025134T3 (en) | Process for preparing a concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use | |
| Gordon | The relationship between language and behaviour. | |
| IE871567L (en) | Method for treating depression | |
| MD1716B2 (en) | Use of melatonin for treatment of patients dependent on benzodiazepine | |
| Aurela | A systematic storytelling therapy. | |
| Eletsky | Effect of hemosorption on the time-course of neuropsychic disturbances in patients with psoriasis and neurodermatitis. | |
| Bogdanov et al. | Methods for the restoration of motor functions in patients with acute and early recovery periods of cerebral stroke | |
| Semke | Feasibility of pathogenetic therapy for hysteria | |
| ROBINSON | Comments on Ethical Protocol | |
| RU93008692A (ru) | Способ рефлексотерапии | |
| IT1247488B (it) | Uso del pirrolidoncarbossilato di piridossina per il trattamento dei disturbi affettivi depressivi | |
| RU93027571A (ru) | Способ усиления противоопухолевого эффекта лучевой терапии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |